Protection of the oral mucosa by salivary histatin-5 against Candida albicans in an ex vivo murine model of oral infection

FEMS Yeast Research

Volumn 10, Issue 5, 2010, Pages 597-604

  Peters, Brian M ^a   Zhu, Jingsong ^b   Fidel Jr , Paul L ^c   Scheper, Mark A ^b   Hackett, William ^b   El Shaye, Sara ^b   Jabra Rizk, Mary Ann ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

antimicrobial peptide; Candida albicans; innate immunity; murine model; salivary histatin 5

Indexed keywords

HISTATIN 5; PROTEINASE; HISTATIN;

ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; COLONY FORMING UNIT; DRUG EFFECT; FEMALE; FUNGAL CELL; HISTOPATHOLOGY; MOUSE; NONHUMAN; PROTECTION; SALIVA; THRUSH; ANIMAL; BACTERIAL COUNT; CANDIDIASIS, ORAL; CHEMISTRY; CYTOCHEMISTRY; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; IN VITRO STUDY; MICROBIAL VIABILITY; MICROSCOPY; MOUTH MUCOSA;

ANIMALS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; HISTATINS; HISTOCYTOCHEMISTRY; IN VITRO TECHNIQUES; MICE; MICROBIAL VIABILITY; MICROSCOPY; MOUTH MUCOSA; SALIVA;

EID: 77954482491     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2010.00632.x     Document Type: Article

References (26)

1. Albrecht A, Felk A, Pichova I et al 2006) Glycosylphosphatidylinositol- anchored proteases of Candida albicans target proteins necessary for both cellular processes and host-pathogen interactions. J Biol Chem 281 : 688 694.
2. Calderone RA (2002) Candida and Candidiasis. ASM Press
3. de Repentigny L, Lewandowski D Jolicoeur P (2004) Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 17 : 729 759.
4. Edgar WM (1992) Saliva: its secretion, composition and functions. Brit Dent J 172 : 305 312.
5. Edgerton M, Koshlukova SE, Lo TE, Chrzan BG, Straubinger RM Raj PA (1998) Candidacidal activity of salivary histatins. J Biol Chem 272 : 20438 20447.
6. Fidel PL Jr. (2006) Candida-host interactions in HIV disease: relationships in oropharyngeal candidiasis. Adv Dent Res 19 : 80 84.
7. Gillum AM, Tsay EY Kirsch DR (1984) Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet 198 : 179 182.
8. Gyurko C, Lendenmann U, Helmerhorst EJ, Troxler RF Oppenheim FG (2001) Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Antonie van Leeuwenhoek 79 : 297 309.
9. Helmerhorst EJ, van't Hof W, Veerman ECI, Simoons-Smit I Nieuw Amerongen AV (1997) Synthetic histatin analogues with broad-spectrum antimicrobial activity. Biochem J 326 : 39 45.
10. Helmerhorst EJ, Hodgson R, van't Hof W, Veerman EC, Allison C Nieuw Amerongen AV (1999a) The effects of histatin-derived basic antimicrobial peptides on oral biofilms. J Dent Res 78 : 1245 1250.
11. Helmerhorst EJ, Reijnders IM, van't Hof W, Simoons-Smit I, Veerman ECI Nieuw Amerongen AV (1999b) Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides. Antimicrob Agents Ch 43 : 702 704.
12. Humphrey SP Williamson RT (2001) A review of saliva: normal composition, flow, and function. J Prosthet Dent 85 : 162 169.
13. Kamagata-Kiyoura Y, Abe S, Yamaguchi H Nitta T (2004) Protective effects of human saliva on experimental murine oral candidiasis. J Infect Chemother 10 : 253 255.
14. Klein RS, Harris CA, Small CB, Moll B, Lesser M Friedland GH (1984) Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. New Engl J Med 311 : 354 358.
15. Koshlukova SE, Araujo MWB, Baev D Edgerton M (2000) Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect Immun 68 : 6848 6856.
16. Meiller TF, Hube B, Schild L et al 2009) A novel immune evasion strategy of Candida albicans: proteolytic cleavage of a salivary antimicrobial peptide. PLoS ONE 4 : e5039.
17. Naglik JR, Challacombe SJ Hube B (1999) Candida albicans secreted aspartyl proteinases in virulence and pathogenesis. Infect Immun 67 : 2740 2745.
18. Nikawa H, Jin C, Makihira S, Hamada T Samaranayake LP (2002) Susceptibility of Candida albicans isolates from the oral cavities of HIV-positive patients to histatin-5. J Prosthet Dent 88 : 263 267.
19. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD Troxler RF (1988) Histatins, a novel family of histidine-rich proteins in human parotid secretion. J Biol Chem 263 : 7472 7477.
20. Perlroth J, Choi B Spellberg B (2007) Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45 : 321 346.
21. Situ H Bobek LA (2000) In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1. Antimicrob Agents Ch 44 : 1485 1493.
22. Torres SR, Garzino-Demo A, Meeks V, Meiller TF Jabra-Rizk MA (2008) Salivary histatin-5 and oral fungal colonization in HIV+ individuals. Mycoses 52 : 11 15.
23. Tsai H Bobek LA (1997) Studies of the mechanism of human salivary histatin-5 candidacidal activity with histatin-5 variants and azole-sensitive and -resistant Candida species. Antimicrob Agents Ch 41 : 2224 2228.
24. van't Hof W, Reijnders IM, Helmerhorst EJ, Walgreen-Weterings E, Simoons-Smit IM, Veerman EC Amerongen AV (2000) Synergistic effects of low doses of histatin 5 and its analogues on amphotericin B anti-mycotic activity. Antonie van Leeuwenhoek 78 : 163 169.
25. van't Hof W, Veerman ECI, Helmerhorst EJ Nieuw Amerongen AV (2001) Antimicrobial peptides: properties and applicability. Biol Chem 382 : 597 619.
26. Villar CC, Kashleva H, Nobile CJ, Mitchell AP Dongari-Bagtzoglou A (2007) Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor rim 101p and protease Sap5p. Infect Immun 75 : 2126 2135.